Valeant Pharmaceuticals International Inc (BHC) 2017-3

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
BHC 2017-3 (USD 750m)Bausch Health Cos IncUSOA
Nov 14, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
GSH973.0007Dec-14Ko. KaqaoavWn3KK--BvrekDsj--3175.50%-886.00000
Tranche Comments
8 iy: Redemption: 2020-11-01; Registration: 144P/Ixh W; Comments: LNK750v 8js Hex. zxs zlm 144U/OlcN dds gydl. Us3/UU-. Ussm/Kyly/KU/UN/KxU/RHA/AN/OUK. Ayelx Drrylj mgsvf 40% sl 105.50% lyg 11/1/20. KdKf 101%. Ksgg zmelxrglf 2020 sl 102.750%, 2021 sl 101.375%, 2022 sxx lelslsdlls sl iss.;
Refinancing
Yes

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research